Shares of Sun Pharmaceutical fell as much as 2.8% on Tuesday to an intraday low of Rs 1,610 on the BSE after Bank of America Securities downgraded the stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower-than-expected execution in speciality drugs. Bank of America Securities lowered its target price on Sun Pharma … Read more
Drug major Sun Pharmaceutical Industries on Thursday reported a 20% fall in its Q1 consolidated net profit to Rs 2,278 crore compared to Rs 2,836 crore in the year ago period. The company’s revenue from operation stood at Rs 13,786 crore which was up 10% versus Rs 12,525 crore posted in the corresponding quarter of … Read more
Brokerage firms like UBS have a neutral rating on Bharti Airtel, while Nomura has buy ratings on Macrotech Developers and BPCL. Additionally, Nuvama and Jefferies hold buy ratings on Federal Bank and Sun Pharma, respectively. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: UBS on Bharti Airtel: … Read more